Home/Filings/4/0001546417-19-000030
4//SEC Filing

Kappitt Michael 4

Accession 0001546417-19-000030

CIK 0001546417other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 7:26 PM ET

Size

39.9 KB

Accession

0001546417-19-000030

Insider Transaction Report

Form 4
Period: 2019-02-22
Kappitt Michael
EVP & President of Carrabba's
Transactions
  • Exercise/Conversion

    Common Stock

    2019-02-22+2,80612,397 total
  • Exercise/Conversion

    Common Stock

    2019-02-22+1,98213,695 total
  • Tax Payment

    Common Stock

    2019-02-22$21.97/sh684$15,02711,713 total
  • Tax Payment

    Common Stock

    2019-02-25$21.94/sh1,092$23,95816,639 total
  • Exercise/Conversion

    Common Stock

    2019-02-25+2,80019,439 total
  • Exercise/Conversion

    Common Stock

    2019-02-26+2,76321,520 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-02-252,8002,801 total
    Exercise: $0.00Common Stock (2,800 underlying)
  • Exercise/Conversion

    Common Stock

    2019-02-25+4,50717,731 total
  • Tax Payment

    Common Stock

    2019-02-25$21.94/sh682$14,96318,757 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-02-221,9825,948 total
    Exercise: $0.00Common Stock (1,982 underlying)
  • Tax Payment

    Common Stock

    2019-02-22$21.97/sh471$10,34813,224 total
  • Tax Payment

    Common Stock

    2019-02-26$21.61/sh673$14,54420,847 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-02-222,8065,611 total
    Exercise: $0.00Common Stock (2,806 underlying)
Holdings
  • Restricted Stock Units

    Exercise: $0.00Common Stock (8,942 underlying)
    8,942
  • Restricted Stock Units

    Exercise: $0.00Common Stock (6,250 underlying)
    6,250
  • Stock Option (right to buy)

    Exercise: $21.29Exp: 2029-02-19Common Stock (23,236 underlying)
    23,236
  • Stock Option (right to buy)

    Exercise: $24.10Exp: 2028-02-23Common Stock (18,570 underlying)
    18,570
  • Stock Option (right to buy)

    Exercise: $17.27Exp: 2027-02-24Common Stock (26,733 underlying)
    26,733
  • Stock Option (right to buy)

    Exercise: $17.15Exp: 2026-02-25Common Stock (26,113 underlying)
    26,113
  • Stock Option (right to buy)

    Exercise: $17.80Exp: 2026-03-01Common Stock (50,000 underlying)
    50,000
  • Stock Option (right to buy)

    Exercise: $25.36Exp: 2025-02-26Common Stock (15,074 underlying)
    15,074
  • Stock Option (right to buy)

    Exercise: $25.32Exp: 2024-02-27Common Stock (12,490 underlying)
    12,490
  • Stock Option (right to buy)

    Exercise: $23.87Exp: 2024-01-02Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $17.40Exp: 2023-02-26Common Stock (10,021 underlying)
    10,021
Footnotes (19)
  • [F1]These shares of common stock were acquired upon the vesting and settlement of certain restricted stock units.
  • [F10]These restricted stock units, in the original grant amount of 11,201, began vesting in four equal annual installments on February 25, 2017.
  • [F11]These restricted stock units, in the original amount of 8,942, will begin vesting in three equal annual installments on February 19, 2020.
  • [F12]These restricted stock units, in the original grant amount of 25,000, began vesting in four equal annual installments on February 12, 2017.
  • [F13]These stock options, in the original grant amount of 23,236, will begin vesting in three equal annual installments on February 19, 2020.
  • [F14]These stock options, in the original grant amount of 18,570, began vesting in four equal annual installments beginning on February 23, 2019.
  • [F15]These stock options, in the original grant amount of 26,733, began vesting in four equal annual installments on February 24, 2018.
  • [F16]These stock options, in the original grant amount of 26,113, began vesting in four equal annual installments on February 25, 2017.
  • [F17]These stock options, in the original grant amount of 50,000, began vesting in four equal annual installments on February 12, 2017.
  • [F18]These stock options, in the original grant amount of 15,074, began vesting in four equal annual installments on February 26, 2016.
  • [F19]These stock options are fully vested.
  • [F2]These common shares were delivered to the issuer to pay for the applicable withholding tax due upon vesting of certain restricted stock units.
  • [F3]Represents shares of common stock acquired upon vesting of certain performance-based share units as a result of achievement of performance goals.
  • [F4]These shares were withheld by the issuer to pay for the applicable withholding tax due upon vesting of certain performance-based share units.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • [F6]These restricted stock units were surrendered in exchange for shares of common stock of the issuer.
  • [F7]These restricted stock units, in the original grant amount of 11,222, began vesting in four equal annual installments on February 24, 2018.
  • [F8]This field is not applicable.
  • [F9]These restricted stock units, in the original grant amount of 7,930, began vesting in four equal annual installments on February 23, 2019.

Issuer

Bloomin' Brands, Inc.

CIK 0001546417

Entity typeother

Related Parties

1
  • filerCIK 0001666526

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:26 PM ET
Size
39.9 KB